Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads

Pain Physician

Volumn 15, Issue 1, 2012, Pages 75-85

  Pak, Jaewoo ^a  

^a Miplant Stems Clinic   (South Korea)

Author keywords

Adipose tissue derived stem cells; ADSC; Avascular necrosis; Bone necrosis; Bone regeneration; Cell based treatment; Femoral head osteonecrosis; Hip pain

Indexed keywords

CALCIUM CHLORIDE; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; TRAMADOL;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE DERIVED STEM CELL; ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE REGENERATION; CASE REPORT; FEMUR HEAD NECROSIS; FUNCTIONAL RATING INDEX; HARRIS HIP SCORE; HIP PAIN; HUMAN; HUMAN TISSUE; KOREA; LONG TERM CARE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PAIN PARAMETERS; RANGE OF MOTION; RATING SCALE; STAGING; THROMBOCYTE RICH PLASMA; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADIPOSE TISSUE; ADULT; BONE AND BONES; BONE REGENERATION; FEMUR HEAD NECROSIS; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PAIN; PLATELET-RICH PLASMA; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84856466024     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Jones K, Seshadri T, Krantz R, Keating A, Ferguson P. Cell-based therapies for osteonecrosis of the femoral head. Biol Blood Marrow Transplant 2008; 14:1081-1087.
2. Glimcher MJ, Kenzora JE. The biology of osteonecrosis of the human femoral head and its clinical implications: II. The pathological changes in the femoral head as an organ and in the hip joint. Clin Orthop Relat Res 1979; 139:283-312.
3. Inoue A, Ono K. A histological study of idiopathic avascular necrosis of the head of the femur. J Bone Joint Surg Br 1979; 61-B:138-143.
4. Springfield DS, Enneking WJ. Surgery for aseptic necrosis of the femoral head. Clin Orthop Relat Res 1978; 103:175-185.
5. Mont MA, Carbone JJ, Fairbank AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res 1996; 324:169-178.
6. Chandler FA. Coronary disease of the hip. 1949. Clin Orthop Relat Res 2001; 386:7-10.
7. Saito S, Ohzono K, Ono K. Early arteriopathy and postulated pathogenesis of osteonecrosis of the femoral head. The intracapital arterioles. Clin Orthop Relat Res 2001; 277:98-110.
8. Jones JP Jr. Fat embolism and osteonecrosis. Orthop Clin North Am 1985; 16:595-633.
9. Hungerford DS, Lennox DW. The importance of increased intraosseous pressure in the development of osteonecrosis of the femoral head: Implications for treatment. Orthop Clin North Am 1985; 16:635-654.
10. Saito S, Inoue A, Ono K. Intramedullary haemorrhage as a possible cause of avascular necrosis of the femoral head. The histology of 16 femoral heads at the silent stage. J Bone Joint Surg Br 1987; 69:346-351.
11. Wang TY, Avlonitis EG, Relkin R. Systemic necrotizing vasculitis causing bone necrosis. Am J Med 1988; 84:1085-1086.
12. Jones JP Jr. Fat embolism, intravascular coagulation, and osteonecrosis. Clin Orthop Relat Res 1993; 292:294-308.
13. Garino JP, Steinberg ME. Total hip arthroplasty in patients with avascular necrosis of the femoral head: A 2- to 10- year follow-up. Clin Orthop Relat Res 1997; 334:108-115.
14. Katz RL, Bourne RB, Rorabeck CH, Mc-Gee H. Total hip arthroplasty in patients with avascular necrosis of the hip. Follow- up observations on cementless and cemented operations. Clin Orthop Relat Res 1992; 281:145-151.
15. Billing E, May JW. Historical review and present status of free fat graft autotransplantation in plastic and reconstructive surgery. Plast Reconstr Surg 1989; 83:368-381.
16. Korean Food and Drug Administration. Cell therapy. In Korean Food and Drug Administration Rules and Regulations. Seoul, Korea: Food and Drug Administration; Chapter 2, Section 12.
17. Barry FP. Mesenchymal stem cell therapy in joint disease. Novartis Found Symp 2003; 249:86-96, discussion 96-102, 170-174, 239-241.
18. Gimble J. Adipose tissue-derived therapeutics. Expert Opin Biol Ther 2003; 3: 705-713.
19. Caplan AI. Mesenchymal stem cell. J Orthop Res 1991; 9:641-650.
20. Carter DR, Beaupré GS, Giori NJ, Helms JA. Mechanobiology of skeletal regeneration. Clin Orthop Relat Res 1998; (355 Suppl):S41-55.
21. Johnstone B, JU Yoo. Autologous mesenchymal progenitor cells in articular cartilage repair. Clin Orthop Relat Res 1999; (367 Suppl):S156-162.
22. Luyten FP. Mesenchymal stem cells in osteoarthritis. Curr Opin Rheumatol 2004; 16:599-603.
23. Magne D, Vinatier C, Julien M, Weiss P, Guicheux J. Mesenchymal stem cell therapy to rebuild cartilage. Trends Mol Med 2005; 11:519-526. Epub 2005 Oct 5.
24. Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003; 48:3464-3474.
25. Nevo Z, Robinson D, Horowitz S, Hasharoni A, Yayon A. The manipulated mesenchymal stem cells in regenerated skeletal tissues. Cell Transplant 1998; 7:63-70.
26. Noel D, Djouad F, Jorgense C. Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. Curr Opin Investig Drugs 2002; 3:1000-1004.
27. Schaffler A, Buchler A. Concise Review: Adipose tissue-derived stromal cells- basic and clinical implications for novel cell-based therapies. Stem Cells 2007; 25:818-827.
28. Traktuev DO, Merfeld-Clauss S, Li J Kolonin M, Arap W, Pasqualini R, Johnstone BH, March KL. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 2008; 102:77-85.
29. Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 2002; 405:14-23.
30. Gangji V. Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells: A pilot study. J Bone Joint Surg Am 2004: 86:1153-1160.
31. Gangji V, Toungouz M, Hauzeur JP. Stem cell therapy for osteonecrosis of the femoral head. Expert Opin Biol Ther 2005; 5:437-442.
32. Centeno CJ, Buse D, Kisiday J, Keohan C, Freeman M, Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician 2008; 11:343-353.
33. Wang BL Sun W, Shi ZC, Zhang NF, Yue DB, Guo WS, Xu SQ, Lou JN, Li ZR. Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg 2009; 130:1-7.
34. Pak J. Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with adipose-tissue- derived stem cells. J Med Case Reports 2011; 5:296.
35. Parsons P, Hesselden K, Butcher A, Maughan J, Milner R, Horner A. The biological effect of platelet rich-plasma on the fracture healing process. J Bone Joint Surg Br 2009; 91B(Suppl 2):293-c.
36. Li N, Yuan R, Chen T, Chen L, Jin X. Effect of platelet-rich plasma and latissimus dorsi muscle flap on osteogenesis and vascularization of tissue-engineered bone in dog. J Oral Maxillofac Surg 2009; 67:1850-1858.
37. Wu W, Chen F, Liu Y, Ma Q, Mao T. Autologous injectable tissue-engineered cartilage by using platelet-rich plasma: Experimental study in a rabbit model. J Oral Maxillofac Surg 2007; 65:1951-1957.
38. Caplan A, Correa D. PDGF for bone formation and regeneration: New insights into a novel mechanism involving MSCs. J Orthop Res 2011; 12:1795-1803.
39. Martineau I, Lacoste E, Gagnon G. Effects of calcium and thrombin on growth factor release from platelet concentrates: Kinetics and regulation of endothelial cell proliferation. Biomaterials 2004, 25:4489-4502.
40. Childs JD, Piva SR. Psychometric properties of the functional rating index in patients with low back pain. Eur Spine J 2005; 14:1008-12.
41. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13:4279-4295.
42. Aust L, Devlin B, Foster SJ, Halvorsen YD, Hicok K, du Laney T, Sen A, Willingmyre GD, Gimble JM. Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 2004; 7-14.